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Continuous success in transplantation have revolu-
tionized the practice of medicine. This burgeoning success 
has acted upon both society and medicine itself 
Why has there been such an impact on medicine? 
Up to now, transplantation techniques have been expen-
sive. Relatively few lives, probably less than 100,000 have 
been actually saved. 
A CHANGE IN PHILOSOPHY 
The reason is that transplantation has made possible 
a fundamental philosophic departure in the way that health 
care is delivered. Until 50 or 60 years ago, practitioners 
of medicine observed a~d presided over lethal diseases, 
powerless to provide much more than a priestly function. 
This began to change with increasingly specific drugs 
such as antibiotics, but for most organ specific chronic 
disorders, a rear guard strategy was all that could be 
offered. Patients with failing kidneys, livers or hearts 
could be treated with diet, medicines, or with operations 
which often were illogically designed. Suddenly, with the 
advent of transplantation, it became possible for the first 
time in human history to provide exactly what was needed: 
a completely new organ. 
But immunosupression was too poor to apply this 
thrilling concept widely until the 1980's. Then, with the 
introduction of cyclosporine, it became obvious that a 
great escape hatch had not only been formed but that 
future judgement in the care of organ specific diseases 
would have to be in the new perspective of possible even-
tual organ replacement. Nowhere was this more clear 
than in liver disease in which mutilating operations in 
the portal hilum such as portacaval shunts were virtually 
abandoned overnight since they jeopardized eventual can-
didacy for liver transplantation. Similar examples with 
renal and cardiac disease easily could be cited. 
ADMINISTRATIVE AND EDUCA TIONAL 
CHANGES 
In addition, transplantation has forced a change in 
the way that medicine has been taught and organized. 
The breadth and depth of expertise required to be at 
the State of the Art, much less progressive, in transplan-
tation, have gone beyond the grasp of single individuals. 
Interdisciplinary teams have been formed within medical 
schools and hospitals that have cut across classical depar-
tamental and divisional lines. These new alliances have 
changed the face not only of practice but of research 
and have had wide-ranging influence on the development 
of other special fields. 
RESEARCH POTENTIAL 
A special note should be made about the extraor-
dinary influence of transplantation on both basic and 
clinical research. Modern immunology has been in part-
nership with, not sponsorship of, transplantation. Our 
understanding of autoimmune diseases, and the appro-
priate treatment of these disorders owes much to observa-
tions after transplantation, an undertaking that first crea-
tes and then attempts to control the autoimmune disease 
known as rejection. 
Thus, transplantation became the Pandora's box oJ 
20th century science. 
WHY AN IMPACT ON SOCIETY? 
It is obvious that there is no more intimate human 
contact than with transplantation in wich the objective 
is to transfer living tissue under the most perfect possible 
conditions. The corollary is that diseases including can-
cer, can be transplanted in the process. Most recently, 
AIDS carriers have been found in every major transplant 
program in wich screening of the postoperative recipient 
population has been carried out systematically. Many 
of these patients already had been infected before trans-
plantation in the course of their original illness by blood 
transfusions and other factors. A few obtained the AIDS 
virus from infected donors before donor testing was avai-
lable. In almost hal]; the time and circumstances of infec-
tion never could be determined. The conclusion is clear, 
as it was with hepatitis, that precautions are crucial to 
prevent the transplant centers from being disease reser-
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voirs from which other patients as well as health care 
personnel can be infected. 
HOW SOCIETY HAS CHANGED 
The impact has been seen everywhere; in Ihe law, 
in government, in philosophy, and in the perception of 
ethics. The leaders of all of the world's great religions 
have had to consider the implications of transplantation 
in their beliefs. 
The new issues began to emerge 25 years ago. Before 
then transplantation was not a practical therapeutic op-
tion. In 1962 and 1963, using the drug combination of 
azathioprine and prednisone, . apparently' healthy 'reci-
pients of kidneys began to emerge from clinics in increa-
sing numbers. 
In a meeting convened in London in 1965 to consider 
what the early successes in renal transplantation truly 
meant, many topics including living donation, human 
experimentation and brain death were discussed. 
The Nuremberg code and the Helsinki declaration 
of 1964 were used as the frame work to judge what had 
already been done in transplantation and what might 
be considered next. The Helsinki declaration distingui-
shed between non-therapeutic research designed solely 
for the objective of acquiring information as opposed 
to the use of unproven therapy in which the subjects 
who bore the risks were the same as those who stood 
to benefit. 
Transplantation was a classical example of thera-
peutic investigation. The risks and benefits of so-called 
innovative procedures could be weighed without equivo-
cation for the first recipients of kidneys, livers, hearts, 
and other organs. 
Although stones could be thrown, there were no solid 
hits. What was done in transplantation in those days was 
sometimes foolish, but it was never ignoble. 
In later times, there has been a tendency to construct 
formal and sometimes elaborate "human experiments" 
comparing different kinds of therapy. I once heard it 
seriously proposed that bonafide candidates for liver or 
heart transplantation should be randomized into those 
receiving therapy vs. untreated controls. I describe such 
suggestions as randomized "trialomania". This was a 
fair criticism. However, "trialomania" can present with 
more subtle symptoms, such as insistence upon carrying 
on randomized trials before learning how to use new 
therapeutic tools. There is no better way to discredit pro-
mising new developments. 
Even worse than premature randomization is rando-
mization after the fact. For a randomized clinical trial 
to be carried out ethically, the necessary starting point 
is a null hypothesis of no treatment difference. A question 
that physicians must ask before assigning patients to a 
randomized trial is whether they would allow therapy 
to be decided by lot for themselves or their family mem-
bers if they suffered from the same disease. 
THE SIMPLE PAST 
It is easier for me to talk about the past than to 
face the future. The work we did was once so simple. 
That has all changed. What was a crusade when it was 
not a reliable way of treatment became a business when 
it turned successful. The magical days were gone, not 
overnight but over a quarter of a century. This may have 
been just as well since victories easily won are lightly 
held. 
I do not really have a grand vision of that happened 
in the last 25 years, only details. I can see a thousand 
air strips rolled into one, days turned into nights, flashing 
lights, mournful sirens, pale faces drained of hope in 
donor hospitals, faces grown beautiful with restored vita-
lity and visions of the future in the transplant centers. 
Someone once told me that the greatest gift of God was 
to see something of yourself, if only once, in the face 
of another human being. Those working in transplan-
talion have known this experience in the best. of times 
and this experiences has made bearable the worst of times. 
I have always been proud to be a surgeon. Sixty 
years ago another surgeon wrote. "To give courage to 
those who need it, to restore the desire for life to those 
who have abandoned it with our skill to heal disease 
or check its course, this is our great privilege. Ours are 
not the concerns of ordinary life. We who ... are doomed 
to go in corr..pany with pain and fear and bloodshed 
have a higher mission than other men, and it is for us 
to see that we are not uflworrhy"lIl. 
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